蛋白质基因分析揭示了转运中的生物标志物和Transthyretin Amyloid Cardiomyopathy中失调的途径
Ree Lu1, Ani Nalbandian1, Keitaro Akita1
1Division of Cardiology, Department of Medicine (R.L., A.N., K.A., M.S.M., Y.J.S.), Columbia University Irving Medical Center, New York.
Circulation. Heart failure
|January 22, 2026
概括
这项研究确定了与心力衰竭 (HF) 控制组相比,在跨氨酸氨基酸心肌病 (ATTR-CM) 中的独特蛋白质组概况. 在ATTR-CM.中发现PI3K-Akt和JAK-STAT等关键信号通路受到失调.
科学领域:
- 心脏病学 心脏病学
- 蛋白质组学是指蛋白质组学.
- 分子生物学分子生物学
背景情况:
- 晶胺氨基酸心肌病变 (ATTR-CM) 是一种导致心力衰竭 (HF) 的限制性心肌病变.
- 参与ATTR-CM病原发生的特定信号通路在很大程度上仍未定义.
- 了解这些途径对于确定治疗点至关重要.
研究的目的:
- 识别和描述在ATTR-CM中失调的信号通路.
- 为了比较ATTR-CM患者与对照组的蛋白质组概况.
主要方法:
- 采用病例控制研究设计,将ATTR-CM病例与内部控制 (高血压左心室缩) 和外部控制 (HF) 进行比较.
- 对7289种蛋白质进行了等离子体蛋白质组学分析.
- 为了分类,开发了一种稀疏的部分最小平方差分分析模型,并使用HF控制器进行外部验证.
主要成果:
- 一个基于蛋白质组学的模型以89%的准确性 (AUC=0.89) 将ATTR-CM与对照区分开来.
- 确定PI3K-Akt和JAK-STAT信号通路在ATTR-CM.中显著失调.
- 已知的途径,包括补充和凝血级联,也显示出调节障碍.
结论:
- 与HF相比,ATTR-CM表现出独特的蛋白质原子签名.
- 这项研究阐明了ATTR-CM中新的和已知的失调信号通路.
- 这些发现有助于更好地了解ATTR-CM病理生理学.
相关概念视频
03:03Amyloid Fibrils
11.7K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.7K
03:03Amyloid Fibrils
6.4K
6.4K
01:30Cardiomyopathy II: Dilated Cardiomyopathy
492
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
492
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
488
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
488
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
433
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
433
01:25Cardiomyopathy I: Introduction and Classification
521
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
521